Analysts think PODD stock price could increase by 27%
May 06, 2025, 11:25 AM
23.29%
What does PODD do
Insulet, headquartered in Acton, Massachusetts, develops and markets insulin infusion systems, including the Omnipod 5 Automated Insulin Delivery System, for insulin-dependent diabetes. The company employs 3,000 staff and went public in 2007.
26 analysts think PODD stock price will increase by 26.88%. The current median analyst target is $328.44 compared to a current stock price of $258.86. The lowest analysts target is $236.34 and the highest analyst target is $367.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
